Let's work together and help protect kids against potentially deadly diseases with the DTaP-IPV/Hib vaccine.1
Pentacel is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease due to H influenzae type b. Pentacel is approved for use as a 4-dose series in children 6 weeks through 4 years of age (prior to fifth birthday).
Quadracel is indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis. A single dose of Quadracel is approved as a fifth dose in the diphtheria, tetanus, pertussis (DTaP) vaccination series, and as a fourth or fifth dose in the inactivated poliovirus (IPV) vaccination series, in children 4 through 6 years of age whose previous DTaP vaccine doses have been with Pentacel and/or DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed), and/or VAXELIS® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine).
Start your primary DTaP immunization series in children 6 weeks through 4 years of age (prior to 5th birthday) with 4 doses of Pentacel, the only DTaP-IPV-Hib combination.1
Finish the DTaP series with Quadracel as the 5th dose in children 4 through 6 years of age.2
The only Hib-containing DTaP-IPV
combination vaccine with a
4-dose indication1
The same liquid DTaP-IPV component as
in Pentacel1,2
Antigens
DTaP-IPV/Hib1
DTaP-IPV2
Schedule
Doses at 2, 4, 6, and 15-18 months1,3
A dose at 4-6 years2,3
*Data are not available on the safety and effectiveness of using mixed sequences of Pentacel and DTaP vaccine from different manufacturers.
Our cast is tiny but very chatty. Hear what they have to say about Pentacel.
Birth Birth |
1 Month 1 Mo. |
2 Months 2 Mos. |
4 Months 4 Mos. |
6 Months 6 Mos. |
9 Months 9 Mos. |
12 Months 12 Mos. |
15 Months 15 Mos. |
18 Months 18 Mos. |
19-23 Months 19-23 Mos. |
2-3 Years 2-3 Yrs. |
4-6 Years 4-6 Yrs. |
---|---|---|---|---|---|---|---|---|---|---|---|
Hep B | Hep B | Hep B | |||||||||
DTaP | DTaP | DTaP | DTaP | DTaP | |||||||
IPV | IPV | IPV | IPV | ||||||||
Hib | Hib | Hib | Hib | Hib | |||||||
RV | RV | RVb | |||||||||
PCV | PCV | PCV | PCV | PCV | |||||||
Influenza (yearly) | |||||||||||
MMRc | MMR | MMR | |||||||||
Varicella | Varicella | ||||||||||
Hep A | Hep A (2-dose series) | ||||||||||
MenACWY | |||||||||||
PPSV | |||||||||||
Birth Birth |
1 Month 1 Mo. |
2 Months 2 Mos. |
4 Months 4 Mos. |
6 Months 6 Mos. |
9 Months 9 Mos. |
12 Months 12 Mos. |
15 Months 15 Mos. |
18 Months 18 Mos. |
19-23 Months 19-23 Mos. |
2-3 Years 2-3 Yrs. |
4-6 Years 4-6 Yrs. |
---|---|---|---|---|---|---|---|---|---|---|---|
Hep B | Hep B | Hep B | |||||||||
Hib | |||||||||||
RV | RV | RVb | |||||||||
PCV | PCV | PCV | PCV | PCV | |||||||
Influenza (yearly) | |||||||||||
MMRc | MMR | MMR | |||||||||
Varicella | Varicella | ||||||||||
Hep A | Hep A (2-dose series) | ||||||||||
MenACWY | |||||||||||
PPSV | |||||||||||
Birth Birth |
1 Month 1 Mo. |
2 Months 2 Mos. |
4 Months 4 Mos. |
6 Months 6 Mos. |
9 Months 9 Mos. |
12 Months 12 Mos. |
15 Months 15 Mos. |
18 Months 18 Mos. |
19-23 Months 19-23 Mos. |
2-3 Years 2-3 Yrs. |
4-6 Years 4-6 Yrs. |
---|---|---|---|---|---|---|---|---|---|---|---|
Hep B | Hep B | Hep B | |||||||||
Hib | |||||||||||
RV | RV | RVb | |||||||||
PCV | PCV | PCV | PCV | PCV | |||||||
Influenza (yearly) | |||||||||||
MMRc | MMR | MMR | |||||||||
Varicella | Varicella | ||||||||||
Hep A | Hep A (2-dose series) | ||||||||||
MenACWY | |||||||||||
PPSV | |||||||||||
Contraindications to vaccination with Pentacel or Quadracel vaccine include: a severe allergic reaction (e.g., anaphylaxis) to any ingredient of the vaccine, or following any other diphtheria toxoid-, tetanus toxoid-, pertussis antigen-containing vaccine, inactivated poliovirus vaccine, or Haemophilus influenzae type b vaccine (Pentacel only); encephalopathy within 7 days after a previous dose of a pertussis antigen-containing vaccine with no other identifiable cause; or a progressive neurologic disorder.